DoD Lupus, Idea Award | W81XWH 21 LRP IA

Opportunity Information: Apply for W81XWH 21 LRP IA

The DoD Lupus Research Program (LRP) Idea Award is a funding opportunity designed to push lupus research in genuinely new directions by supporting innovative, high-risk/high-reward projects. The intent is to back early, creative concepts that could lead to a critical discovery or a major advancement in how lupus is understood, studied, or ultimately addressed. Applicants are expected to propose an idea that does more than extend prior work in small steps; the program is explicitly not meant to fund incremental progress on an already established research line. Instead, the proposal should clearly explain how the work will add new knowledge to the lupus field, generate new hypotheses, or open an innovative and novel course of investigation. Preliminary data are not required, which underscores that the program is willing to consider well-justified concepts even at an early stage, particularly when successful results could position a team to pursue larger follow-on funding later.

The review emphasis centers on innovation, impact, and a strong research strategy. On innovation, applicants need to spell out exactly what makes the idea new, such as introducing a new paradigm, applying a fresh perspective to a long-standing problem, or using a creative approach that could reveal new avenues for lupus investigation. On impact, the proposal must make a persuasive case that if the research succeeds, it will matter in an area of high importance to lupus and have meaningful implications for people living with the disease. The program draws a firm line that projects mainly extending previously published work in a stepwise manner are unlikely to be viewed as impactful. On research strategy, the application should demonstrate a clear scientific rationale and thoughtful methodology, reflecting a deep understanding of lupus biology or disease mechanisms. Methods can be novel, but they can also be grounded in existing approaches as long as they are driven by a strong rationale and an in-depth reading of the literature.

Programmatic fit is also a key requirement. Proposed research must address at least one of the Fiscal Year 2021 LRP Focus Areas (the specific focus areas are referenced in the full announcement, and applicants are expected to align their work to at least one). In addition, clinical trials are not allowed under this announcement, meaning the funded activities must remain on the non-clinical-trial side of research (for example, preclinical studies, mechanistic work, biomarker discovery that does not constitute a clinical trial, or other foundational research approaches consistent with the rules of the program).

Awards under this opportunity are issued as federal assistance agreements, meaning the government is providing support to carry out a public purpose rather than purchasing a product or service for direct government use. The assistance agreement can be either a grant or a cooperative agreement, with the deciding factor being the expected level of DoD involvement during the project. If substantial involvement by the funding agency is not anticipated, the award is typically a grant; if substantial involvement is anticipated (such as collaboration, participation, or intervention in the research), it may be structured as a cooperative agreement. The final award type and start date are set during negotiations, and any substantial involvement would be specified in the award.

From a funding and timing standpoint, the anticipated total costs for the full period of performance for an FY21 LRP Idea Award are capped at $300,000 per award. The program planned an overall allocation of about $1.2 million to fund roughly four applications, although actual awards depend on federal fund availability, application volume, and the outcomes of scientific and programmatic review. The opportunity was issued by the Department of Defense (Department of the Army, USAMRAA) under Funding Opportunity Number W81XWH-21-LRP-IA, with an original closing date of September 22, 2021, and an expected award issuance deadline no later than September 30, 2022. Eligible applicants were listed as unrestricted (open to any entity type, subject to any additional eligibility clarifications in the full announcement). The funding is associated with CFDA 12.420, and awards were expected to be made using FY21 funds that would remain available for use through September 30, 2027.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Lupus, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 26, 2021.
• Applicants must submit their applications by Sep 22, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 4 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 LRP IA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: